BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22184635)

  • 21. TLR4 and Toll-IL-1 receptor domain-containing adapter-inducing IFN-beta, but not MyD88, regulate Escherichia coli-induced dendritic cell maturation and apoptosis in vivo.
    De Trez C; Pajak B; Brait M; Glaichenhaus N; Urbain J; Moser M; Lauvau G; Muraille E
    J Immunol; 2005 Jul; 175(2):839-46. PubMed ID: 16002681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B and T lymphocyte attenuator inhibits LPS-induced endotoxic shock by suppressing Toll-like receptor 4 signaling in innate immune cells.
    Kobayashi Y; Iwata A; Suzuki K; Suto A; Kawashima S; Saito Y; Owada T; Kobayashi M; Watanabe N; Nakajima H
    Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5121-6. PubMed ID: 23479601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TLR4-mediated activation of dendritic cells by the heat shock protein DnaK from Francisella tularensis.
    Ashtekar AR; Zhang P; Katz J; Deivanayagam CC; Rallabhandi P; Vogel SN; Michalek SM
    J Leukoc Biol; 2008 Dec; 84(6):1434-46. PubMed ID: 18708593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of Toll-like receptors by Burkholderia pseudomallei.
    West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
    BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alarmin augments the antitumor immunity of lentiviral vaccine in ectopic, orthotopic and autochthonous hepatocellular carcinoma mice.
    Liu Z; Lu Z; Jing R; Zuo B; Gao X; Han G; Qi H; Wu L; Liu Y; Yin H
    Theranostics; 2019; 9(14):4006-4018. PubMed ID: 31281528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR4 signaling induces functional nerve growth factor receptor p75NTR on mouse dendritic cells via p38MAPK and NF-kappa B pathways.
    Jiang Y; Chen G; Zheng Y; Lu L; Wu C; Zhang Y; Liu Q; Cao X
    Mol Immunol; 2008 Mar; 45(6):1557-66. PubMed ID: 18006062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine.
    Park HJ; Jang GY; Kim YS; Park JH; Lee SE; Vo MC; Lee JJ; Han HD; Jung ID; Kang TH; Park YM
    J Immunother Cancer; 2019 Feb; 7(1):60. PubMed ID: 30819254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice.
    Chen CY; Ueha S; Ishiwata Y; Yokochi S; Yang D; Oppenheim JJ; Ogiwara H; Shichino S; Deshimaru S; Shand FHW; Shibayama S; Matsushima K
    J Immunother Cancer; 2019 Jan; 7(1):21. PubMed ID: 30696484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant.
    Okamoto M; Oh-E G; Oshikawa T; Furuichi S; Tano T; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Himeno K; Sato M; Ohkubo S
    Clin Diagn Lab Immunol; 2004 May; 11(3):483-95. PubMed ID: 15138173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells.
    Dillon S; Agrawal A; Van Dyke T; Landreth G; McCauley L; Koh A; Maliszewski C; Akira S; Pulendran B
    J Immunol; 2004 Apr; 172(8):4733-43. PubMed ID: 15067049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic and differential modulation of immune responses by Hsp60 and lipopolysaccharide.
    Osterloh A; Kalinke U; Weiss S; Fleischer B; Breloer M
    J Biol Chem; 2007 Feb; 282(7):4669-4680. PubMed ID: 17164250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipopolysaccharide induces cell volume increase and migration of dendritic cells.
    Gröbner S; Lukowski R; Autenrieth IB; Ruth P
    Microbiol Immunol; 2014 Jan; 58(1):61-7. PubMed ID: 24236732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation.
    Shen H; Tesar BM; Walker WE; Goldstein DR
    J Immunol; 2008 Aug; 181(3):1849-58. PubMed ID: 18641322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipopolysaccharide-Induced CD300b Receptor Binding to Toll-like Receptor 4 Alters Signaling to Drive Cytokine Responses that Enhance Septic Shock.
    Voss OH; Murakami Y; Pena MY; Lee HN; Tian L; Margulies DH; Street JM; Yuen PS; Qi CF; Krzewski K; Coligan JE
    Immunity; 2016 Jun; 44(6):1365-78. PubMed ID: 27261276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the innate immune responses of porcine monocyte-derived dendritic cells and splenic dendritic cells stimulated with LPS.
    Qu X; Cinar MU; Fan H; Pröll M; Tesfaye D; Tholen E; Looft C; Hölker M; Schellander K; Uddin MJ
    Innate Immun; 2015 Apr; 21(3):242-54. PubMed ID: 24648487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway.
    Uto T; Akagi T; Yoshinaga K; Toyama M; Akashi M; Baba M
    Biomaterials; 2011 Aug; 32(22):5206-12. PubMed ID: 21492934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
    Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
    Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia Attenuates Colonic Innate Immune Response and Inhibits TLR4/NF-κB Signaling Pathway in Lipopolysaccharide-Induced Colonic Epithelial Injury Mice.
    Han Y; Jia R; Zhang J; Zhu Q; Wang X; Ji Q; Zhang W
    J Interferon Cytokine Res; 2023 Jan; 43(1):43-52. PubMed ID: 36603105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.